149 related articles for article (PubMed ID: 37855432)
1. Functionalized liposomes: an enticing nanocarrier for management of glioma.
Peddinti V; Rout B; Agnihotri TG; Gomte SS; Jain A
J Liposome Res; 2024 Jun; 34(2):349-367. PubMed ID: 37855432
[TBL] [Abstract][Full Text] [Related]
2. An update on actively targeted liposomes in advanced drug delivery to glioma.
Mojarad-Jabali S; Farshbaf M; Walker PR; Hemmati S; Fatahi Y; Zakeri-Milani P; Sarfraz M; Valizadeh H
Int J Pharm; 2021 Jun; 602():120645. PubMed ID: 33915182
[TBL] [Abstract][Full Text] [Related]
3. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
[TBL] [Abstract][Full Text] [Related]
4. Recent Approaches and Success of Liposome-Based Nano Drug Carriers for the Treatment of Brain Tumor.
Shaw TK; Paul P
Curr Drug Deliv; 2022; 19(8):815-829. PubMed ID: 34961462
[TBL] [Abstract][Full Text] [Related]
5. Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB.
Chen C; Duan Z; Yuan Y; Li R; Pang L; Liang J; Xu X; Wang J
ACS Appl Mater Interfaces; 2017 Feb; 9(7):5864-5873. PubMed ID: 28128553
[TBL] [Abstract][Full Text] [Related]
6. Blood-Brain Barrier- and Blood-Brain Tumor Barrier-Penetrating Peptide-Derived Targeted Therapeutics for Glioma and Malignant Tumor Brain Metastases.
Chen L; Zeng D; Xu N; Li C; Zhang W; Zhu X; Gao Y; Chen PR; Lin J
ACS Appl Mater Interfaces; 2019 Nov; 11(45):41889-41897. PubMed ID: 31615203
[TBL] [Abstract][Full Text] [Related]
7. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
Zhao X; Ye Y; Ge S; Sun P; Yu P
Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
[TBL] [Abstract][Full Text] [Related]
8. Research Progress on Nanoplatforms and Nanotherapeutic Strategies in Treating Glioma.
Qiao L; Yang H; Shao XX; Yin Q; Fu XJ; Wei Q
Mol Pharm; 2022 Jul; 19(7):1927-1951. PubMed ID: 35499303
[TBL] [Abstract][Full Text] [Related]
9. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
Lakkadwala S; Singh J
Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346
[TBL] [Abstract][Full Text] [Related]
10. Glioma targeting peptide modified apoferritin nanocage.
Zhai M; Wang Y; Zhang L; Liang M; Fu S; Cui L; Yang M; Gong W; Li Z; Yu L; Xie X; Yang C; Yang Y; Gao C
Drug Deliv; 2018 Nov; 25(1):1013-1024. PubMed ID: 29726297
[TBL] [Abstract][Full Text] [Related]
11. Ligand-modified homologous targeted cancer cell membrane biomimetic nanostructured lipid carriers for glioma therapy.
Chen M; Cui Y; Hao W; Fan Y; Zhang J; Liu Q; Jiang M; Yang Y; Wang Y; Gao C
Drug Deliv; 2021 Dec; 28(1):2241-2255. PubMed ID: 34668811
[TBL] [Abstract][Full Text] [Related]
12. Dual-modified natural high density lipoprotein particles for systemic glioma-targeting drug delivery.
Cui L; Wang Y; Liang M; Chu X; Fu S; Gao C; Liu Q; Gong W; Yang M; Li Z; Yu L; Yang C; Su Z; Xie X; Yang Y; Gao C
Drug Deliv; 2018 Nov; 25(1):1865-1876. PubMed ID: 30474437
[TBL] [Abstract][Full Text] [Related]
13. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
[TBL] [Abstract][Full Text] [Related]
14. Dual-Modified Novel Biomimetic Nanocarriers Improve Targeting and Therapeutic Efficacy in Glioma.
Fu S; Liang M; Wang Y; Cui L; Gao C; Chu X; Liu Q; Feng Y; Gong W; Yang M; Li Z; Yang C; Xie X; Yang Y; Gao C
ACS Appl Mater Interfaces; 2019 Jan; 11(2):1841-1854. PubMed ID: 30582685
[TBL] [Abstract][Full Text] [Related]
15. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
[TBL] [Abstract][Full Text] [Related]
16. Sequential Targeting in Crosslinking Nanotheranostics for Tackling the Multibarriers of Brain Tumors.
Wu H; Lu H; Xiao W; Yang J; Du H; Shen Y; Qu H; Jia B; Manna SK; Ramachandran M; Xue X; Ma Z; Xu X; Wang Z; He Y; Lam KS; Zawadzki RJ; Li Y; Lin TY
Adv Mater; 2020 Apr; 32(14):e1903759. PubMed ID: 32078198
[TBL] [Abstract][Full Text] [Related]
17. Overcoming the blood-brain barrier for chemotherapy: limitations, challenges and rising problems.
Wang Z; Sun H; Yakisich JS
Anticancer Agents Med Chem; 2014; 14(8):1085-93. PubMed ID: 23092271
[TBL] [Abstract][Full Text] [Related]
18. Enhanced BBB and BBTB penetration and improved anti-glioma behavior of Bortezomib through dual-targeting nanostructured lipid carriers.
Farshbaf M; Mojarad-Jabali S; Hemmati S; Khosroushahi AY; Motasadizadeh H; Zarebkohan A; Valizadeh H
J Control Release; 2022 May; 345():371-384. PubMed ID: 35301054
[TBL] [Abstract][Full Text] [Related]
19. Biotin and glucose co-modified multi-targeting liposomes for efficient delivery of chemotherapeutics for the treatment of glioma.
Liu Q; Zhou L; Lu R; Yang C; Wang S; Hai L; Wu Y
Bioorg Med Chem; 2021 Jan; 29():115852. PubMed ID: 33189509
[TBL] [Abstract][Full Text] [Related]
20. Natural polymeric nanocarriers in malignant glioma drug delivery and targeting.
Gao Y; Wang R; Zhao L; Liu A
J Drug Target; 2021 Nov; 29(9):960-973. PubMed ID: 33745392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
